Tuesday, October 25, 2016

Zithromax


Zithromax is a brand name of azithromycin, approved by the FDA in the following formulation(s):


ZITHROMAX (azithromycin - for suspension; oral)



  • Manufacturer: PFIZER

    Approval date: September 28, 1994

    Strength(s): EQ 1GM BASE/PACKET [RLD]


  • Manufacturer: PFIZER

    Approval date: October 19, 1995

    Strength(s): EQ 100MG BASE/5ML [AB], EQ 200MG BASE/5ML [RLD][AB]

ZITHROMAX (azithromycin - injectable; injection)



  • Manufacturer: PFIZER

    Approval date: January 30, 1997

    Strength(s): EQ 500MG BASE/VIAL [RLD][AP]

ZITHROMAX (azithromycin - tablet; oral)



  • Manufacturer: PFIZER

    Approval date: June 12, 1996

    Strength(s): EQ 600MG BASE [RLD][AB]


  • Manufacturer: PFIZER

    Approval date: July 18, 1996

    Strength(s): EQ 250MG BASE [AB]


  • Manufacturer: PFIZER

    Approval date: May 24, 2002

    Strength(s): EQ 500MG BASE [AB]

Has a generic version of Zithromax been approved?


A generic version of Zithromax has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zithromax and have been approved by the FDA:


azithromycin for suspension; oral



  • Manufacturer: PLIVA

    Approval date: July 5, 2006

    Strength(s): EQ 100MG BASE/5ML [AB], EQ 200MG BASE/5ML [AB]


  • Manufacturer: SANDOZ

    Approval date: September 18, 2006

    Strength(s): EQ 100MG BASE/5ML [AB], EQ 200MG BASE/5ML [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: June 24, 2008

    Strength(s): EQ 100MG BASE/5ML [AB], EQ 200MG BASE/5ML [AB]

azithromycin injectable; injection



  • Manufacturer: APP PHARMS

    Approval date: December 13, 2005

    Strength(s): EQ 500MG BASE/VIAL [AP]


  • Manufacturer: GLAND PHARMA LTD

    Approval date: November 9, 2009

    Strength(s): EQ 500MG BASE/VIAL [AP]


  • Manufacturer: HOSPIRA

    Approval date: June 26, 2009

    Strength(s): EQ 500MG BASE/VIAL [AP], EQ 500MG BASE/VIAL [AP]


  • Manufacturer: PLIVA HRVATSKA DOO

    Approval date: January 18, 2007

    Strength(s): EQ 500MG BASE/VIAL [AP]


  • Manufacturer: SAGENT STRIDES

    Approval date: March 24, 2009

    Strength(s): EQ 500MG BASE/VIAL [AP]

azithromycin tablet; oral



  • Manufacturer: APOTEX CORP

    Approval date: July 13, 2011

    Strength(s): EQ 250MG BASE [AB], EQ 500MG BASE [AB], EQ 600MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: January 8, 2007

    Strength(s): EQ 600MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: May 30, 2007

    Strength(s): EQ 250MG BASE [AB], EQ 500MG BASE [AB]


  • Manufacturer: PLIVA

    Approval date: November 14, 2005

    Strength(s): EQ 250MG BASE [AB], EQ 500MG BASE [AB], EQ 600MG BASE [AB]


  • Manufacturer: SANDOZ

    Approval date: November 14, 2005

    Strength(s): EQ 250MG BASE [AB], EQ 500MG BASE [AB], EQ 600MG BASE [AB]


  • Manufacturer: TEVA

    Approval date: November 14, 2005

    Strength(s): EQ 250MG BASE [AB], EQ 500MG BASE [AB], EQ 600MG BASE [AB]


  • Manufacturer: WOCKHARDT

    Approval date: February 11, 2008

    Strength(s): EQ 250MG BASE [AB], EQ 500MG BASE [AB], EQ 600MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zithromax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Azithromycin dihydrate
    Patent 6,268,489
    Issued: July 31, 2001
    Inventor(s): Allen; Douglas J. M. & Nepveux; Kevin M.
    Assignee(s): Pfizer Inc.
    Non-hygroscopic, azithromycin (9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin) dihydrate and a process therefor.
    Patent expiration dates:

    • July 31, 2018
      ✓ 
      Drug substance



See also...

  • Zithromax Consumer Information (Drugs.com)
  • Zithromax Consumer Information (Wolters Kluwer)
  • Zithromax Single-Dose Packet Consumer Information (Wolters Kluwer)
  • Zithromax Suspension Consumer Information (Wolters Kluwer)
  • Zithromax Tablets Consumer Information (Wolters Kluwer)
  • Zithromax Consumer Information (Cerner Multum)
  • Zithromax TRI-PAK Consumer Information (Cerner Multum)
  • Zithromax Z-Pak Consumer Information (Cerner Multum)
  • Zithromax Advanced Consumer Information (Micromedex)
  • Zithromax Intravenous Advanced Consumer Information (Micromedex)
  • Zithromax Tri-Pak Advanced Consumer Information (Micromedex)
  • Zithromax Z-Pak Advanced Consumer Information (Micromedex)
  • Azithromycin Consumer Information (Drugs.com)
  • Azithromycin Consumer Information (Wolters Kluwer)
  • Azithromycin Extended-Release Oral Suspension Consumer Information (Wolters Kluwer)
  • Azithromycin Single-Dose Packet Consumer Information (Wolters Kluwer)
  • Azithromycin Suspension Consumer Information (Wolters Kluwer)
  • Azithromycin Tablets Consumer Information (Wolters Kluwer)
  • Azithromycin Consumer Information (Cerner Multum)
  • Azithromycin Advanced Consumer Information (Micromedex)
  • Azithromycin Intravenous Advanced Consumer Information (Micromedex)
  • Azithromycin AHFS DI Monographs (ASHP)
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)